|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.430
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.331
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.331
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.321
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.318
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.277
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.277
|
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.260
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.241
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.238
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.232
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.224
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.223
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.220
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.219
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.214
|
|
|
|
renal inner medulla development
|
GO:0072053 |
3 |
0.206
|
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.203
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.203
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.202
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.201
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.195
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.190
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.181
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.174
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.167
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.167
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.165
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.165
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.162
|
|
|
|
gastrin induced gastric acid secretion
|
GO:0001698 |
1 |
0.160
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.155
|
|
|
|
fibroblast growth factor production
|
GO:0090269 |
4 |
0.154
|
|
|
|
mesonephric duct formation
|
GO:0072181 |
2 |
0.153
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.149
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.147
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.139
|
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.135
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.132
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.132
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.132
|
|
|
|
establishment of organ orientation
|
GO:0048561 |
1 |
0.131
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.127
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.125
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.122
|
|
|
|
spemann organizer formation
|
GO:0060061 |
2 |
0.122
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.120
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.120
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.119
|
|
|
|
cervix development
|
GO:0060067 |
2 |
0.119
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.118
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.117
|
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.117
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.116
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.116
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.114
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.114
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.113
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.112
|
|
|
|
inner medullary collecting duct development
|
GO:0072061 |
2 |
0.106
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.104
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.104
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.102
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.101
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.101
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.101
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.101
|
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.100
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.100
|
|
|
|
cerebellum formation
|
GO:0021588 |
1 |
0.100
|
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.100
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.098
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.096
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.096
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.095
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.094
|
|
|
|
digestion
|
GO:0007586 |
40 |
0.093
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.090
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.090
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.088
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.087
|
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.084
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.084
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.083
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.083
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.082
|
|
|
|
regulation of saliva secretion
|
GO:0046877 |
2 |
0.082
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.082
|
|
|
|
metanephric collecting duct development
|
GO:0072205 |
7 |
0.082
|
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.082
|
|
|
|
tertiary branching involved in mammary gland duct morphogenesis
|
GO:0060748 |
3 |
0.081
|
|
|
|
lateral sprouting involved in mammary gland duct morphogenesis
|
GO:0060599 |
2 |
0.081
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.080
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.080
|
|
|
|
kidney rudiment formation
|
GO:0072003 |
3 |
0.080
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.079
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.079
|
|
|
|
oxygen homeostasis
|
GO:0032364 |
2 |
0.079
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.079
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.078
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.078
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.077
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.077
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.076
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.076
|
|
|
|
lung induction
|
GO:0060492 |
3 |
0.076
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.075
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
40 |
0.075
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.075
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.074
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.074
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.074
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.073
|
|
|
|
vasodilation by norepinephrine epinephrine involved in regulation of systemic arterial blood pressure
|
GO:0002025 |
3 |
0.073
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.073
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.072
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.072
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.072
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.072
|
|
|
|
prostate gland epithelium morphogenesis
|
GO:0060740 |
31 |
0.070
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.070
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.070
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.069
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.069
|
|
|
|
regulation of camp metabolic process
|
GO:0030814 |
30 |
0.068
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.068
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.068
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.067
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.067
|
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.066
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.066
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.066
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.065
|
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.065
|
|
|
|
hair cycle phase
|
GO:0044851 |
16 |
0.064
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.063
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.063
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.063
|
|
|
|
outer medullary collecting duct development
|
GO:0072060 |
1 |
0.063
|
|
|
|
neuroepithelial cell differentiation
|
GO:0060563 |
37 |
0.062
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.062
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.062
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.061
|
|
|
|
positive regulation of interleukin 8 secretion
|
GO:2000484 |
1 |
0.061
|
|
|
|
interleukin 1 beta secretion
|
GO:0050702 |
16 |
0.061
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.061
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.060
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.060
|
|
|
|
establishment or maintenance of polarity of embryonic epithelium
|
GO:0016332 |
1 |
0.060
|
|
|
|
positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000081 |
1 |
0.060
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.060
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.060
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.059
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.059
|
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
2 |
0.059
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.058
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.058
|
|
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.058
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.058
|
|
|
|
positive regulation of stress activated mapk cascade
|
GO:0032874 |
48 |
0.058
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.057
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.057
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.056
|
|
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.056
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.056
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.056
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.056
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.055
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.055
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.055
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.055
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.055
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.054
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.054
|
|
|
|
regulation of fibroblast growth factor production
|
GO:0090270 |
4 |
0.054
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.054
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.054
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.054
|
|
|
|
regulation of chondrocyte differentiation
|
GO:0032330 |
33 |
0.054
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.054
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.054
|
|
|
|
establishment of planar polarity involved in nephron morphogenesis
|
GO:0072046 |
1 |
0.054
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.054
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.053
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.053
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.053
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.053
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.053
|
|
|
|
negative regulation of mesenchymal cell proliferation
|
GO:0072201 |
3 |
0.052
|
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.052
|
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.052
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.052
|
|
|
|
regulation of cell cell adhesion mediated by cadherin
|
GO:2000047 |
2 |
0.052
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.051
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.051
|
|
|
|
regulation of systemic arterial blood pressure by norepinephrine epinephrine
|
GO:0001993 |
8 |
0.051
|
|
|
|
prostate gland morphogenesis
|
GO:0060512 |
32 |
0.051
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.051
|
|
|
|
lung field specification
|
GO:0060424 |
3 |
0.051
|
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.051
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.051
|
|
|
|
dna templated transcriptional preinitiation complex assembly
|
GO:0070897 |
4 |
0.051
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.050
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.050
|
|
|
|
establishment of anatomical structure orientation
|
GO:0048560 |
1 |
0.050
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.050
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.050
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.049
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.049
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.049
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.049
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.048
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.048
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.048
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.047
|
|
|
|
heart growth
|
GO:0060419 |
45 |
0.047
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.047
|
|
|
|
hypophysis morphogenesis
|
GO:0048850 |
3 |
0.047
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.047
|
|
|
|
regulation of interleukin 1 production
|
GO:0032652 |
26 |
0.047
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.047
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.046
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.046
|
|
|
|
midbrain hindbrain boundary maturation during brain development
|
GO:0022004 |
1 |
0.046
|
|
|
|
non canonical wnt signaling pathway via jnk cascade
|
GO:0038031 |
3 |
0.046
|
|
|
|
cellular response to parathyroid hormone stimulus
|
GO:0071374 |
2 |
0.045
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.045
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.045
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.045
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.045
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.045
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.045
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.045
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.045
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.044
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.044
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.044
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.044
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.043
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.043
|
|
|
|
ribosomal small subunit assembly
|
GO:0000028 |
1 |
0.043
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.043
|
|
|
|
somatostatin signaling pathway
|
GO:0038170 |
2 |
0.043
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.043
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.043
|
|
|
|
positive regulation of transforming growth factor beta2 production
|
GO:0032915 |
2 |
0.043
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.042
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.042
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.042
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.042
|
|
|
|
non canonical wnt signaling pathway involved in heart development
|
GO:0061341 |
3 |
0.041
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.041
|
|
|
|
positive regulation of cyclic nucleotide biosynthetic process
|
GO:0030804 |
24 |
0.041
|
|
|
|
regulation of epidermis development
|
GO:0045682 |
33 |
0.041
|
|
|
|
positive regulation of fat cell differentiation
|
GO:0045600 |
32 |
0.041
|
|
|
|
negative regulation of androgen biosynthetic process
|
GO:2000180 |
1 |
0.041
|
|
|
|
rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0051123 |
3 |
0.041
|
|
|
|
cell cell adhesion mediated by cadherin
|
GO:0044331 |
5 |
0.041
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.041
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.041
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.041
|
|
|
|
positive regulation of glycolytic process
|
GO:0045821 |
4 |
0.041
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.041
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.041
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.040
|
|
|
|
prostate gland development
|
GO:0030850 |
48 |
0.040
|
|
|
|
phospholipase c activating serotonin receptor signaling pathway
|
GO:0007208 |
1 |
0.040
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.040
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.040
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.040
|
|
|
|
spemann organizer formation at the anterior end of the primitive streak
|
GO:0060064 |
1 |
0.040
|
|
|
|
interleukin 1 secretion
|
GO:0050701 |
16 |
0.040
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.040
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.040
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.040
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.040
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.040
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.040
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.040
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.040
|
|
|
|
histamine induced gastric acid secretion
|
GO:0001697 |
1 |
0.039
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.039
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.039
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.039
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.039
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.039
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.039
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.039
|
|
|
|
negative regulation of testosterone biosynthetic process
|
GO:2000225 |
1 |
0.039
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.039
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.038
|
|
|
|
negative regulation of blood pressure
|
GO:0045776 |
22 |
0.038
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.038
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.038
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.038
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.038
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.037
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.037
|
|
|
|
negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:0072040 |
4 |
0.037
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.037
|
|
|
|
tissue regeneration
|
GO:0042246 |
22 |
0.037
|
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.037
|
|
|
|
renal outer medulla development
|
GO:0072054 |
2 |
0.037
|
|
|
|
maintenance of cell number
|
GO:0098727 |
3 |
0.037
|
|
|
|
regulation of purine nucleotide biosynthetic process
|
GO:1900371 |
34 |
0.037
|
|
|
|
memory
|
GO:0007613 |
58 |
0.036
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.036
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.036
|
|
|
|
adenylate cyclase activating g protein coupled receptor signaling pathway
|
GO:0007189 |
30 |
0.036
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.036
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.036
|
|
|
|
positive regulation of jnk cascade
|
GO:0046330 |
46 |
0.036
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.036
|
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
31 |
0.036
|
|
|
|
wnt signaling pathway calcium modulating pathway
|
GO:0007223 |
2 |
0.036
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.036
|
|
|
|
positive regulation of cell cell adhesion mediated by cadherin
|
GO:2000049 |
2 |
0.035
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.035
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.035
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.035
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.035
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.035
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.035
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.035
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.034
|
|
|
|
sensory perception of taste
|
GO:0050909 |
18 |
0.034
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.034
|
|
|
|
positive regulation of camp metabolic process
|
GO:0030816 |
19 |
0.034
|
|
|
|
regulation of interleukin 1 beta production
|
GO:0032651 |
25 |
0.034
|
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.034
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.034
|
|
|
|
establishment of blood brain barrier
|
GO:0060856 |
8 |
0.034
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.034
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.034
|
|
|
|
canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation
|
GO:0044343 |
1 |
0.034
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.033
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.033
|
|
|
|
regulation of excitatory postsynaptic membrane potential
|
GO:0060079 |
41 |
0.033
|
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.033
|
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
39 |
0.033
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.033
|
|
|
|
sensitization
|
GO:0046960 |
2 |
0.033
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.033
|
|
|
|
positive regulation of anagen
|
GO:0051885 |
1 |
0.033
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.033
|
|
|
|
positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis
|
GO:0072108 |
3 |
0.033
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.033
|
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.033
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.033
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.033
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.032
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.032
|
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.032
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.032
|
|
|
|
metanephric nephron tubule formation
|
GO:0072289 |
4 |
0.032
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.032
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.032
|
|
|
|
bone trabecula formation
|
GO:0060346 |
9 |
0.031
|
|
|
|
foregut regionalization
|
GO:0060423 |
3 |
0.031
|
|
|
|
regulation of cyclic nucleotide biosynthetic process
|
GO:0030802 |
31 |
0.031
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.031
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.031
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.031
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.031
|
|
|
|
positive regulation of branching involved in lung morphogenesis
|
GO:0061047 |
4 |
0.031
|
|
|
|
learning
|
GO:0007612 |
98 |
0.031
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.031
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.031
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.031
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.031
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.031
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.031
|
|
|
|
axial mesoderm formation
|
GO:0048320 |
3 |
0.031
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.031
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.030
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.030
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.030
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.030
|
|
|
|
interferon gamma production
|
GO:0032609 |
67 |
0.030
|
|
|
|
response to parathyroid hormone
|
GO:0071107 |
3 |
0.030
|
|
|
|
non canonical wnt signaling pathway via mapk cascade
|
GO:0038030 |
3 |
0.030
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.030
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.030
|
|
|
|
g protein coupled acetylcholine receptor signaling pathway
|
GO:0007213 |
4 |
0.030
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.030
|
|
|
|
endothelial cell development
|
GO:0001885 |
20 |
0.030
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.030
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.030
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.030
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.029
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.029
|
|
|
|
regulation of ketone biosynthetic process
|
GO:0010566 |
2 |
0.029
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.029
|
|
|
|
negative regulation of fibroblast growth factor production
|
GO:0090272 |
2 |
0.029
|
|
|
|
apoptotic process involved in development
|
GO:1902742 |
28 |
0.029
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.029
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.028
|
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.028
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.028
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.028
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.028
|
|
|
|
cell cell junction assembly
|
GO:0007043 |
27 |
0.028
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.028
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.028
|
|
|
|
phospholipase c activating g protein coupled receptor signaling pathway
|
GO:0007200 |
26 |
0.028
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.028
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.028
|
|
|
|
regulation of postsynaptic membrane potential
|
GO:0060078 |
48 |
0.028
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.028
|
|
|
|
endothelium development
|
GO:0003158 |
45 |
0.028
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.027
|
|
|
|
cop9 signalosome assembly
|
GO:0010387 |
2 |
0.027
|
|
|
|
specification of organ identity
|
GO:0010092 |
30 |
0.027
|
|
|
|
mesenchymal cell proliferation
|
GO:0010463 |
44 |
0.027
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.027
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.027
|
|
|
|
camp metabolic process
|
GO:0046058 |
40 |
0.027
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.027
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.027
|
|
|
|
positive regulation of cytoskeleton organization
|
GO:0051495 |
49 |
0.027
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.027
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.027
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.027
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.027
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.027
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.026
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
7 |
0.026
|
|
|
|
positive regulation of the force of heart contraction by chemical signal
|
GO:0003099 |
3 |
0.026
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.026
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.026
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.026
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.026
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.026
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.026
|
|
|
|
cellular response to temperature stimulus
|
GO:0071502 |
2 |
0.026
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.026
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.026
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.026
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.025
|
|
|
|
regulation of cardioblast differentiation
|
GO:0051890 |
3 |
0.025
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.025
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.025
|
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.025
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.025
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.025
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.025
|
|
|
|
interleukin 1 beta production
|
GO:0032611 |
30 |
0.025
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.025
|
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.025
|
|
|
|
mesonephric tubule formation
|
GO:0072172 |
11 |
0.025
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.025
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.024
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.024
|
|
|
|
planar cell polarity pathway involved in heart morphogenesis
|
GO:0061346 |
3 |
0.024
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.024
|
|
|
|
regulation of nucleotide biosynthetic process
|
GO:0030808 |
34 |
0.024
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.024
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.024
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.024
|
|
|
|
operant conditioning
|
GO:0035106 |
2 |
0.024
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.024
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.024
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.024
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.024
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.024
|
|
|
|
positive regulation of transcription initiation from rna polymerase ii promoter
|
GO:0060261 |
5 |
0.023
|
|
|
|
heart trabecula morphogenesis
|
GO:0061384 |
26 |
0.023
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.023
|
|
|
|
negative regulation of serotonin secretion
|
GO:0014063 |
2 |
0.023
|
|
|
|
protein kinase c activating g protein coupled receptor signaling pathway
|
GO:0007205 |
4 |
0.023
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.023
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.023
|
|
|
|
somatostatin receptor signaling pathway
|
GO:0038169 |
2 |
0.023
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.023
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.023
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.023
|
|
|
|
heart induction
|
GO:0003129 |
2 |
0.023
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.023
|
|
|
|
habituation
|
GO:0046959 |
3 |
0.023
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.023
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.023
|
|
|
|
positive regulation of actin filament bundle assembly
|
GO:0032233 |
11 |
0.022
|
|
|
|
steroid biosynthetic process
|
GO:0006694 |
47 |
0.022
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.022
|
|
|
|
positive regulation of hair follicle development
|
GO:0051798 |
6 |
0.022
|
|
|
|
endothelial cell differentiation
|
GO:0045446 |
41 |
0.022
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.022
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.022
|
|
|
|
regulation of cardiac muscle contraction
|
GO:0055117 |
21 |
0.022
|
|
